Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck To Increase Internal R&D But Reduce Outside Deals In 2005

Dec 20 2004

• By The Pink Sheet

Related Content

Merck Adds Phase II Oncology Candidate Via Acquisition Of Aton

Mar 01 2004

Merck Gets Second Chance On Dual PPAR: Will Develop Bristol’s Muraglitazar

May 03 2004

Merck Sees Slightly More Success With External Rx Than Internal Candidates

Oct 11 2004

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window